Pages

Saturday, January 1, 2011

What's the Economic impact of Diabetes?

Economic impact of Diabetes #1

Ping Zhang, PhD; Xinzhi Zhang, MD, PhD; Jonathan Betz Brown, MPP, PhD; Dorte Vistisen, PhD, Richard A. Sicree, MBBS, MPH; Jonathan Shaw, MD; Gregory A. Nichols, MBA, PhD

Summary

Diabetes imposes a large economic burden on the national healthcare system. Healthcare expenditures on diabetes will account for 11.6% of the total healthcare expenditure in the world in 2010. About 95% of the countries covered in this report will spend 5% or more, and about 80% of the countries will spend between 5% and 13% of their total healthcare dollars on diabetes.

Global health expenditures to prevent and treat diabetes and its complications will total at least US dollar (USD) 376 billion in 2010.

By 2030, this number will exceed some USD490 billion. Expressed in International Dollars (ID), which correct for differences in purchasing power, the global expenditures on diabetes will be at least ID418 billion in 2010, and at least ID561 billion in 2030. An average of USD703 (ID878) per person will be spent on diabetes in 2010 globally.

Expenditures spent on diabetes care are not evenly distributed across age and gender groups. More than three-quarters of the global expenditure in 2010 will be used for persons who are between 50 and 80 years of age. Also, more money is expected to be spent on diabetes care for women than for men.

There is a large disparity in healthcare spending on diabetes between regions and countries. More than 80% of the global expenditures on diabetes are made in the world’s economically richest countries, not in the low- and middle-income countries where 80% of people with diabetes will soon live. The North American and Caribbean Region will spend USD214 billion, or 57% of the global total on diabetes in 2010. In contrast, the African Region will spend, in total, USD1.4 billion for diabetes, or 0.4% of the global total.

One country, the United States of America (USA), will spend USD198 billion, or 52.7% of global expenditure. India, the country with the largest population of people living with diabetes, will spend an estimated USD2.8 billion, or less than 1% of the global total. An average of USD 7,383 per person with diabetes will be spent on diabetes-related care in the USA but less than USD10 per person will be spent in Burundi, Côte d’Ivoire and Myanmar.

http://blogimages.bloggen.be/diabetescheck/attach/35597.pdf

www.DEPSYL.com

http://back2basicnutrition.com

http://bionutritionalresearch.olhblogspace.com/

No comments: